NeuroPace Gets FDA Nod
NeuroPace receives FDA approval for AI-driven ECoG Assistant, potentially aiding epilepsy treatment. This may impact medical device stocks.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.